Gainplan’s Evolus EOLS Stock Holding History

Gainplan’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,500	Closed	-$183K	–	47
2019 Q2	$183K	Buy	+12,500	New	+$248K	0.11%	32
2019 Q1	–	Sell	-15,000	Closed	-$179K	–	29
2018 Q4	$179K	Buy	+15,000	New	+$214K	0.17%	17

Other funds holding EOLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wafra Inc New York $5.88M AUM 19.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gainplan's EOLS Position: Q3 2019 in Review

Gainplan sold out of Evolus (EOLS) in Q3 2019, closing a stake of 12,500 shares — an estimated $183K sold.

Gainplan first reported a position in EOLS in Q4 2018 and held it in 2 quarters. The position peaked at $183K in Q2 2019. 95 funds tracked by Wall St. Rank hold EOLS as of Q3 2019.

Gainplan reported no remaining Evolus position as of Q3 2019 after selling out during the quarter.
Gainplan sold 12,500 Evolus shares in Q3 2019, an estimated $183K.
Gainplan first reported a position in Evolus in Q4 2018 and held it in 2 quarters.
Gainplan's Evolus position peaked at $183K in Q2 2019.
95 funds tracked by Wall St. Rank held Evolus as of Q3 2019.

Based on Gainplan's 13F filing for Q3 2019, filed 5 Nov 2019.